Drug Approval | May 19, 2026
FDA expands Enhertu use in early HER2-positive breast cancer
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
AstraZeneca highlighted the move as a major step toward earlier intervention in curable disease
The global diagnostics supplier said the multi-phase expansion aims to deliver more than 60 commercially available recombinant antigen products by 2030
The target reach is of more than 30 million young people and caregivers across 21 countries
The accrued data from the Phase 3 study suggest that the baseline characteristics of the enrolled patients are consistent with those observed in previous studies
Steinhagen brings more than 25 years of leadership experience spanning pharma, biotech and the CRO/CDMO sector
Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
This is an exciting and meaningful milestone for GRIN Therapeutics
The approval enables the company to directly sell health insurance plans to individuals and families while integrating its managed healthcare delivery model into retail offerings
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
